Reliability of the Thoratec Heartmate II Flow Measurements and Alarms in the Presence of Reduced or Non-Existent Flow
| dc.contributor.advisor | Larson, Douglas F. | en_US |
| dc.contributor.author | Hall, Seana G. | |
| dc.creator | Hall, Seana G. | en_US |
| dc.date.accessioned | 2013-06-07T22:20:14Z | |
| dc.date.available | 2013-06-07T22:20:14Z | |
| dc.date.issued | 2013 | |
| dc.identifier.uri | http://hdl.handle.net/10150/293644 | |
| dc.description.abstract | The most recognized risk associated with the HeartMate II is thrombosis. In the presence of developing clot, the HeartMate II Display Monitor and System Controller senses a decrease in pump flow and is accompanied by audible and visual alarms when flow rates drop below a certain threshold; however, when flow is completely inhibited, the Display Monitor and System Controller both fail to indicate that flow has reduced to zero and does not produce any corresponding alarms. To test the efficacy of the HeartMate II alarms, the Donavan Mock was used to simulate the hemodynamics of a typical heart failure patient. The hemodynamics were then improved by the addition of the HeartMate II LVAS. Partially occluding the inflow and outflow of the HeartMate II did display changes in flow and presented with alarms when appropriate; however, complete occlusions of the device failed to produce any alarms or accurate changes in flow. | |
| dc.language.iso | en | en_US |
| dc.publisher | The University of Arizona. | en_US |
| dc.rights | Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. | en_US |
| dc.subject | heart failure | en_US |
| dc.subject | HeartMate II | en_US |
| dc.subject | LVAD | en_US |
| dc.subject | Mechanical Circulatory Support | en_US |
| dc.subject | Medical Pharmacology | en_US |
| dc.subject | alarms | en_US |
| dc.title | Reliability of the Thoratec Heartmate II Flow Measurements and Alarms in the Presence of Reduced or Non-Existent Flow | en_US |
| dc.type | text | en_US |
| dc.type | Electronic Thesis | en_US |
| thesis.degree.grantor | University of Arizona | en_US |
| thesis.degree.level | masters | en_US |
| dc.contributor.committeemember | Dussor, Greg | en_US |
| dc.contributor.committeemember | Smith, Rich | en_US |
| thesis.degree.discipline | Graduate College | en_US |
| thesis.degree.discipline | Medical Pharmacology | en_US |
| thesis.degree.name | M.S. | en_US |
| refterms.dateFOA | 2018-08-30T07:24:08Z | |
| html.description.abstract | The most recognized risk associated with the HeartMate II is thrombosis. In the presence of developing clot, the HeartMate II Display Monitor and System Controller senses a decrease in pump flow and is accompanied by audible and visual alarms when flow rates drop below a certain threshold; however, when flow is completely inhibited, the Display Monitor and System Controller both fail to indicate that flow has reduced to zero and does not produce any corresponding alarms. To test the efficacy of the HeartMate II alarms, the Donavan Mock was used to simulate the hemodynamics of a typical heart failure patient. The hemodynamics were then improved by the addition of the HeartMate II LVAS. Partially occluding the inflow and outflow of the HeartMate II did display changes in flow and presented with alarms when appropriate; however, complete occlusions of the device failed to produce any alarms or accurate changes in flow. |
